Feasibility of Adenovirus-Mediated hNIS Gene Transfer and 131I Radioiodine Therapy as a Definitive Treatment for Localized Prostate Cancer
Authors:
Open Access
- 1 July 2011
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 19 (7) , 1353-1359
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Therapeutic Effect of Sodium Iodide Symporter Gene Therapy Combined With External Beam Radiotherapy and Targeted Drugs That Inhibit DNA RepairMolecular Therapy, 2010
- Targeted Radiotherapy for Prostate Cancer with an Oncolytic Adenovirus Coding for Human Sodium Iodide SymporterClinical Cancer Research, 2009
- Phase I Study of Noninvasive Imaging of Adenovirus-mediated Gene Expression in the Human ProstateMolecular Therapy, 2008
- Prostate Cancer Gene Therapy Clinical TrialsMolecular Therapy, 2007
- Five-year Follow-up of Trial of Replication-competent Adenovirus-mediated Suicide Gene Therapy for Treatment of Prostate CancerMolecular Therapy, 2007
- A Quantitative Method for Measuring Gene Expression Magnitude and Volume Delivered by Gene Therapy VectorsMolecular Therapy, 2004
- Determinants of Prostate Cancer–Specific Survival After Radiation Therapy for Patients With Clinically Localized Prostate CancerJournal of Clinical Oncology, 2002
- Transposition of the Thyroid Iodide Uptake and Organification System in Nonthyroid Tumor Cells by Adenoviral Vector-Mediated Gene TransfersThyroid®, 2002
- In vivo sodium iodide symporter gene therapy of prostate cancerGene Therapy, 2001
- A Novel Three-Pronged Approach to Kill Cancer Cells Selectively: Concomitant Viral, Double Suicide Gene, and RadiotherapyHuman Gene Therapy, 1998